$CMPS Income Statement | Understand Stock

$CMPS

$11.81 +$0.76 (6.88%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
OPERATING EXPENSES:
Research and development
General and administrative
Total operating expenses
LOSS FROM OPERATIONS:
OTHER (EXPENSE) INCOME, NET:
Fair value change of warrant liabilities
Benefit from R&D tax credit
Interest income
Interest expense
Foreign exchange gains (losses)
Fair value change of convertible notes
Fair value change of convertible notes - due to a related party
Other income
Total other (expense) income, net

Loss before income taxes
Income tax benefit (expense)
Net loss
Other comprehensive loss:
Foreign exchange translation adjustment
Comprehensive loss
Net loss per share attributable to ordinary shareholders - basic (in dollars per share)
Net loss per share attributable to ordinary shareholders - diluted (in dollars per share)
Weighted average ordinary shares outstanding - basic (in shares)
Weighted average ordinary shares outstanding - diluted (in shares)

Comments